Analysis of commercially available snake antivenoms reveals high contents of endotoxins in some products
As injectable therapeutics, snake antivenoms must meet specifications for endotoxin content. The Limulus amebocyte lysate (LAL) test was used to evaluate the endotoxin content in several commercially available antivenoms released for clinical use. It was found that some products have endotoxin conce...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-03-01
|
| Series: | Toxicon: X |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590171024000043 |